November 17th, 2013

Transparency, Not Marketing

By Rosemary Gibson
New York Times

Americans have just learned that they need to divorce themselves from a drug-prescribing regimen that has been marketed for decades to supposedly mend broken hearts. We’re now told that the evidence never existed for lowering cholesterol levels to numerical targets by taking statins and other drugs.

Curious minds will ask why a multibillion-dollar medical practice that lacked scientific basis was permitted and paid to subject a large swath of people to a human experiment. Big money means you never have to say you’re sorry.
Electronic records and data mining allow real effects to be distinguished from beliefs formed by marketing and habit.

Read more: http://www.nytimes.com/roomfordebate/2013/11/17/when-medical-experts-disagree/for-medical-advice-transparency-not-marketing

Comments

Add your own Comment

(optional)